System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Fabrice Narducci is an expert in Gynecology at Centre Oscar Lambret (France). As of October 2026, ScienceLeadR ranks Fabrice Narducci in the top 1% of experts worldwide for Urogenital Neoplasms and Genital Neoplasms, Female. Fabrice Narducci has authored 287 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 2 of them ongoing. SLR score: 920 (community average: 125). How the SLR is computed.

LeadR Profile

Fabrice Narducci Centre Oscar Lambret France
920 ScienceLeadR Reputation 920

Unlock

Register Login
Network Map

Gynecology

Subspecialties: Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Lille

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 287

Citations

Citations: 4 857 1st author: 28 Last author: 34 Unique author: 1

Main journals

Int J Gynecol Cancer 46
Gynecol Oncol 27
Bull Cancer 21
Gynecol Obstet Fertil 20
Ann Surg Oncol 12

Best Journals

J Clin Oncol 3
Ann Oncol 1
Lancet Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?].
PMID 42557145 — uterine cervical neoplasms, neoplasms, laparoscopy, robotic surgical procedures		Bull Cancer20260
SpiderMass ambient mass spectrometry and multimodal machine learning enable ex vivo ovarian cancer typing and exploratory immunoscoring.
PMID 42419565 — cells, ovary, neoplasms, classification, machine learning, ovarian neoplasms, learning, tissues		J Adv Res20261
Step-by-step type III total pelvic exenteration with vaginectomy and partial vulvectomy with complex pelvic reconstruction for vaginal recurrence of cervical cancer.
PMID 42238947 — pelvic exenteration, uterine cervical neoplasms, neoplasms, vulvectomy		Gynecol Oncol Rep20260
FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer.
PMID 42140840 — ovary, neoplasms, germ-line mutation, ovarian neoplasms, menopause, salpingo-oophorectomy, mutation, ovariectomy		Int J Gynecol Cancer20260
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database.
PMID 42013623 — cytoreduction surgical procedures, lymph nodes, ovary, neoplasms, drug therapy, lymph, ovarian neoplasms, therapeutics, dissection, prognosis, chemotherapy		Eur J Surg Oncol20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 2

By phase:

N/A 7
Phase 3 4

By status:

Completed 4
Unknown 3
Active not recruiting 2
Not yet recruiting 1
Recruiting 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 0
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Risk reducing Strategies Including Fimbriectomy in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330 — sterilization, menopause, premature, surgical procedures, operative, genetic predisposition to disease, ovary, cardiovascular diseases, neoplasms, cognitive dysfunction, sterilization, tubal, germ-line mutation, osteoporosis, ovarian neoplasms, patient preference, prophylactic surgical procedures, menopause, tissues, genes, brca1, salpingo-oophorectomy, mutation, pelvic neoplasms, fallopian tubes, ovariectomy, carcinoma, women		N/ANot yet recruiting2027
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma		Phase 3Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS